NovoCure NVCR Receivables and prepaid expenses
Receivables and prepaid expenses at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept nvcr:ReceivablesAndPrepaidExpenses.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's receivables and prepaid expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's receivables and prepaid expenses?
- NovoCure (NVCR) reported receivables and prepaid expenses of $53.13M in Q1 2026.
- How has NovoCure's receivables and prepaid expenses changed year-over-year?
- NovoCure's receivables and prepaid expenses increased by 56.1% year-over-year, from $34.04M to $53.13M.
- What is the long-term trend for NovoCure's receivables and prepaid expenses?
- Over 5 years (2020 to 2025), NovoCure's receivables and prepaid expenses has grown at a 22.5% compound annual growth rate (CAGR), from $21.25M to $58.67M.
- What does receivables and prepaid expenses mean?
- This represents the aggregate value of amounts owed to the company by customers for goods or services delivered and payments made in advance for future expenses. It serves as a measure of short-term liquidity and the efficiency of the company's revenue collection cycle. Monitoring this balance helps assess the risk of uncollectible accounts and the timing of cash inflows.